| hOCT1 in complex with nb5660 in inward facing partially open 1 conformation | |
Heteromer
| 21-520 | 100.0 | |
|
| hOCT1 in complex with nb5660 in inward facing fully open conformation | |
Heteromer
| 21-520 | 100.0 | |
|
| hOCT1 in complex with nb5660 in inward facing partially open 2 conformation | |
Heteromer
| 21-520 | 100.0 | |
|
| Cryo-EM structure of the organic cation transporter 1 in the apo state | | monomer | 2-533 | 86.84 | 1×NAG; |
|
| Cryo-EM structure of the organic cation transporter 1 in complex with diphenhydramine | | monomer | 2-533 | 86.84 | 1×NAG; 1×2PM; |
|
| Cryo-EM structure of the organic cation transporter 1 in complex with verapamil | | monomer | 2-533 | 86.84 | 1×NAG; 1×4YH; |
|
| hOCT1 in complex with metformin in outward open conformation | | monomer | 2-532 | 100.0 | 1×MF8; |
|
| hOCT1 in complex with spironolactone in outward facing partially occluded conformation | | monomer | 3-532 | 100 | 1×SNL; |
|
| hOCT1 in complex with metformin in outward occluded conformation | | monomer | 3-532 | 100.0 | 1×MF8; |
|
| hOCT1 in complex with metformin in inward occluded conformation | | monomer | 20-517 | 100.0 | 1×MF8; |
|
| Human OCT1 bound to thiamine in inward-open conformation | | monomer | 19-515 | 100.0 | 1×VIB; |
|
| Human OCT1 (Apo) in inward-open conformation | | monomer | 19-515 | 100.0 | |
|
| Human OCT1 bound to fenoterol in inward-open conformation | | monomer | 19-515 | 100.0 | 1×ZVJ; |
|
| Human OCT1 bound to diltiazem in inward-open conformation | | monomer | 19-514 | 100.0 | 1×C9F; |
|
| Human OCT1 bound to metformin in inward-open conformation | | monomer | 19-514 | 100.0 | 1×MF8; |
|
| hOCT1 in complex with spironolactone in inward facing occluded conformation | | monomer | 23-513 | 100.0 | 1×SNL; |
|